STOCK TITAN

Oncoinvent ASA Stock Price, News & Analysis

BRRGD

Company Description

Oncoinvent ASA (OTC: BRRGD) is a publicly traded company.

This page provides a comprehensive overview of BRRGD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-
Performance 1 year

Latest News

BerGenBio Appoints Olav Hellebø as CEO

management

Oncoinvent ASA has 1 recent news article. Key topics include management. View all BRRGD news →

SEC Filings

No SEC filings available for BRRGD.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Oncoinvent ASA (BRRGD) currently stands at 100 shares, down 75.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 75%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.

Days to Cover History

Last 12 Months

Days to cover for Oncoinvent ASA (BRRGD) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges.